Tag: cardiomyopathy

New HCM Guidelines Make Shared Decision-making Top Priority

Greater involvement of the patient and family in decision-making, clarity on the role of genetic testing and parameters for team-oriented care, and use of high-volume...

New ‘Myotropic’ Class Has Modest HFrEF Benefit

Omecamtiv mecarbil, a member of the novel myotropic drug class that improves cardiac performance, safely produced a significant but modest improvement in heart failure events...

Five Pediatric Heart Health Practices That May Be Unnecessary

Five common therapies and practices related to children’s heart health may be unnecessary, and physicians and parents should be careful about using them, the American...

CDER Chief Reflects on Advances in Rare Diseases

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Dr Janet Woodcock Since joining the Food and Drug Administration in...

Cell Therapy for Anthracycline Cardiomyopathy Safe, Feasible

In yet another trial of cell therapy for heart failure, this time in cancer survivors with anthracycline-induced cardiomyopathy (AIC), administration of allogeneic bone marrow-derived mesenchymal...

Another Study Suggests Lasting COVID-19 Impact on Heart

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A new study using cardiac magnetic resonance (CMR) imaging to examine...

New ESC/EACTS Guideline on Atrial Fibrillation

New atrial fibrillation management guidelines from the European Society of Cardiology (ESC) call for diagnostic confirmation and structured characterization of AF and the need to...

EXPLORER Hints at Potential New Drug Option in Obstructive HCM

An investigational drug that targets part of the molecular machinery underlying obstructive hypertrophic cardiomyopathy (HCM) can improve both symptoms and functional status in patients with...

Low Vitamin D, Heart Damage After ‘Recovery’

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Heart Transplant Activity Plummets Across US During COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. From mid-March to mid-May, heart donor recoveries and heart transplant volume...

COVID-19 Update: Elusive Complication, Remdesivir Toxicity

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Women Thrive on Baroreflex Activation for Heart Failure

The striking gains in functional capacity and quality of life conferred by baroreflex activation therapy in patients with heart failure, as shown in the pivotal...

Mavacamten Phase 2 Results Hopeful in Nonobstructive HCM

An investigational, first-in-class agent showed hypothesis-generating promise in symptomatic adults with nonobstructive hypertrophic cardiomyopathy (HCM), a condition lacking in good treatment options, in an early...

Catheter-Free VT Radio-Ablation ‘Safe, Effective’ at 2 Years

A technique borrowed from radiation oncology that takes the catheter out of catheter ablation continued to put in an impressive performance, observers say, in the...

How to Recognize and Manage Kawasaki-like Syndrome

The involvement of the immune system is therefore very strongly suspected, probably mediated by a bacterial or viral agent, and as such the involvement...

Amal Mattu on COVID-19 and Matters of the Heart

What your doctor is reading on Medscape.com: MAY 08, 2020 — COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, has produced morbidity...